Published in Fundam Appl Toxicol on May 01, 1993
Desensitization of PKA-stimulated ciliary beat frequency in an ethanol-fed rat model of cigarette smoke exposure. Alcohol Clin Exp Res (2004) 1.24
Effects of "second-hand" smoke on structure and function of fibroblasts, cells that are critical for tissue repair and remodeling. BMC Cell Biol (2004) 1.12
Milk-Borne Streptococcic Infections. Am J Public Health Nations Health (1937) 3.33
Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation (1992) 2.98
An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke. Food Chem Toxicol (1998) 2.77
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol (2001) 2.42
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation (1991) 2.33
Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol (2001) 2.14
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J Nucl Med (1991) 2.00
Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microb Pathog (1996) 1.91
Tremorgenic toxin from Penicillium cyclopium grown on food materials. Nature (1968) 1.90
Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis (1992) 1.84
Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA (1995) 1.74
Variability in the measurement of regional left ventricular wall motion from contrast angiograms. Circulation (1983) 1.55
Aflatoxin and Reye's syndrome: a case control study. Pediatrics (1980) 1.50
Dynamic mechanisms in human coronary stenosis. Circulation (1984) 1.49
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke. Food Chem Toxicol (2000) 1.40
Coronary arterial-right heart fistulae. Long-term observations in seven patients. Circulation (1973) 1.37
Bioproduction and purification of rubratoxin B. Appl Microbiol (1968) 1.28
Active and passive smoking and pathological indicators of lung cancer--a report of limited value? JAMA (1993) 1.27
Active and passive smoking and pathological indicators of lung cancer--a report of limited value? JAMA (1993) 1.26
Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A (1989) 1.25
Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb (1993) 1.24
Investigation of reported aflatoxin production by fungi outside the Aspergillus flavus group. Appl Microbiol (1968) 1.22
Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation (1989) 1.21
Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res (1991) 1.21
Teratogenic effects of ochratoxin A in mice. Teratology (1974) 1.18
Intrathoracic spatial location of specified coronary segments on the normal human heart. Applications in quantitative arteriography, assessment of regional risk and contraction, and anatomic display. Circulation (1988) 1.17
Tremorgenic toxins produced by soil fungi. Appl Environ Microbiol (1979) 1.17
The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation (1981) 1.16
Subchronic nose-only inhalation study of propylene glycol in Sprague-Dawley rats. Food Chem Toxicol (1989) 1.14
Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation (1984) 1.13
Coronary vasospasm. Observations linking the clinical spectrum of ischemic heart disease to the dynamic pathology of coronary atherosclerosis. Arch Intern Med (1981) 1.13
A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food Chem Toxicol (2000) 1.11
Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation (1977) 1.11
Comparison of the cytotoxic and mutagenic potential of liquid smoke food flavourings, cigarette smoke condensate and wood smoke condensate. Food Chem Toxicol (1999) 1.10
Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. AIDS (1994) 1.10
Chemical and biological studies of a cigarette that heats rather than burns tobacco. J Clin Pharmacol (1990) 1.10
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol (1998) 1.09
Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb (1992) 1.09
Measurement of respiratory patterns in rodents using whole-body plethysmography and a pneumotachograph. Lab Anim (1981) 1.07
Sidestream cigarette smoke. Circulation (1994) 1.07
Prenatal effects of Ochratoxin A in hamsters. Teratology (1976) 1.06
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation (1999) 1.05
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation (1985) 1.05
Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. Circulation (1986) 1.04
Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harb Symp Quant Biol (1986) 1.03
Aflatoxicosis in swine. J Am Vet Med Assoc (1978) 1.03
Swine aortic smooth muscle in tissue culture. Some effects of purified swine lipoproteins on cell growth and morphology. Circ Res (1976) 0.98
Filovirus clearance in non-human primates. Lancet (1992) 0.97
Production and biological activity of secalonic Acid d. Appl Environ Microbiol (1980) 0.97
Quantification of changes in c-myc mRNA levels in normal human bronchial epithelial (NHBE) and lung adenocarcinoma (A549) cells following chemical treatment. Toxicol Sci (2001) 0.95
Effect of pyrolysis temperature on the mutagenicity of tobacco smoke condensate. Food Chem Toxicol (2001) 0.95
Acute toxicity of penitrem A in dogs. Toxicol Appl Pharmacol (1976) 0.94
Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutat Res (1978) 0.94
Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease. Am J Cardiol (1981) 0.93
Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation (2001) 0.93
High-performance liquid chromatographic analysis of the mycotoxin secalonic acid D and its application to biological fluids. J Chromatogr (1981) 0.93
Arteriographic assessment of coronary atherosclerosis. Review of current methods, their limitations, and clinical applications. Arteriosclerosis (1982) 0.93
Toxicity of Secalonic acid D. J Toxicol Environ Health (1979) 0.92
Lipoprotein (a) and coronary heart disease. Curr Opin Lipidol (1995) 0.92
"IARC group 2B Carcinogens" reported in cigarette mainstream smoke. Food Chem Toxicol (2000) 0.92
Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicol In Vitro (2002) 0.92
Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat Res (1996) 0.91
Mycotoxins: a review of biological effects and their role in human diseases. Clin Toxicol (1980) 0.91
A new digital electronic caliper for measurement of coronary arterial stenosis: comparison with visual estimates and computer-assisted measurements. Am J Cardiol (1984) 0.90
Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res (1989) 0.90
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J (1986) 0.90
The failure of trichothecene mycotoxins and whole cultures of Fusarium tricinctum to cause experimental haemorrhagic syndromes in calves and pigs. Vet Rec (1979) 0.89
Mutagenicity of secalonic acid D in mice. J Environ Pathol Toxicol (1980) 0.89
The genotoxic potential of nicotine and its major metabolites. Mutat Res (1995) 0.89
Hepatic uptake and disposition of aflatoxin B1 in isolated perfused rat liver. Toxicol Appl Pharmacol (1977) 0.89
Quantitative coronary angiography: measurement of the "critical" stenosis in patients with unstable angina and single-vessel disease without collaterals. Circulation (1979) 0.89
Factors influencing patency of saphenous vein grafts. Ann Thorac Surg (1979) 0.89
Quantitative computer techniques for analyzing coronary arteriograms. Prog Cardiovasc Dis (1986) 0.88
Teratogenicity of secalonic acid D in mice. J Toxicol Environ Health (1981) 0.88
Assessment of chemically-induced DNA repair in rat tracheal epithelial cells. Carcinogenesis (1984) 0.87
Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats. Toxicology (1982) 0.87
Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease. J Intern Med (2006) 0.86
Aflatoxin B1 and Reye's syndrome. Lancet (1978) 0.86
Effect of aflatoxin B and rubratoxin B on bacteriophage and rabbit cornea cells. Bull Environ Contam Toxicol (1976) 0.86
"IARC Group 2B carcinogens" reported in cigarette mainstream smoke. Food Chem Toxicol (2001) 0.86
Effects of rubratoxin B on prenatal development in mice. Bull Environ Contam Toxicol (1973) 0.86
Mycotoxin from Penicillium puberulum. J Bacteriol (1967) 0.86
Diastolic augmentation by intra-aortic balloon. Circulatory hemodynamics and treatment of severe, acute left ventricular failure in dogs. J Thorac Cardiovasc Surg (1967) 0.85
Evaluation of the carcinogenic potential of 2,4-dinitrofluorobenzene and its implications regarding mutagenicity testing. Carcinogenesis (1982) 0.84
Teratogenic and dominant lethal studies of patulin in mice. Toxicology (1978) 0.84
Correlation between hydrophobicity of short-chain aliphatic alcohols and their ability to alter plasma membrane integrity. Fundam Appl Toxicol (1997) 0.84
Comparative QSAR evidence for a free-radical mechanism of phenol-induced toxicity. Chem Biol Interact (2000) 0.84
Coronary collateral flow following acute coronary occlusion: a diastolic phenomenon. Cardiovasc Res (1974) 0.84
Evaluation of the genotoxic and cytotoxic potential of mainstream whole smoke and smoke condensate from a cigarette containing a novel carbon filter. Fundam Appl Toxicol (1997) 0.84
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy. J Intern Med (2006) 0.83
The effect of cotinine or cigarette smoke co-administration on the formation of O6-methylguanine adducts in the lung and liver of A/J mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Toxicol Sci (1999) 0.83
High-performance liquid chromatographic analysis of the mycotoxin citrinin and its application to biological fluids. J Chromatogr (1980) 0.83
Noninvasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging. Am Heart J (1982) 0.83
Effects of rubratoxin B on the kinetics of cationic and substrate activation of (Na+-K+)-ATPase and p-nitrophenyl phosphatase. J Biol Chem (1978) 0.83
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res (1996) 0.83
In-vitro exoerythrocytic development of Plasmodium cynomolgi bastianellii: inhibitory activity of monoclonal antibodies against sporozoites of different P. cynomolgi strains and of P. knowlesi. Parasite Immunol (1989) 0.83
Assessment of dioxin and dioxin-like compounds in mainstream smoke from selected US cigarette brands and reference cigarettes. Food Chem Toxicol (2008) 0.83
Effect of prenatal administration of T-2 toxin to mice. Res Commun Chem Pathol Pharmacol (1975) 0.82